Serveur d'exploration Hippolyte Bernheim

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer

Identifieur interne : 000736 ( Main/Exploration ); précédent : 000735; suivant : 000737

Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer

Auteurs : A. Fishman [Israël] ; A. Klein [Israël] ; R. Zemer [Israël] ; S. Zimlichman [Israël] ; J. Bernheim [Israël] ; I. Cohen [Israël] ; M. M. Altaras [Israël]

Source :

RBID : Pascal:00-0311921

Descripteurs français

English descriptors

Abstract

Background. Cytokeratins are constituents of the intermediate filaments (IFs) of epithelial cells which are expressed in various combinations, depending on the type of epithelium and degree of differentiation. We have reported (R. Zemer, A. Fishman, J. Bernheim, S. Zimlichman, O. Markowitz, M. Altaras, and A. Klein, Gynecol Oncol 70:410-413, 1998) on the determination of cytokeratin-20 (CK-20) by reverse transcription polymerase chain reaction (RT-PCR) in the detection of endometrial cancer cells as a potential biomarker. In that study, we also found that by using immunocytochemistry, most carcinomas were found to be negative for CK-20. The sensitivity and specificity rates obtained by using the RT-PCR method were 94.4 and 91%, respectively. Objective. The aim of this study is to investigate the feasibility and potential of the specific mRNA marker, CK-20, to detect endometrial cancer cells-micrometastases (MMs)-by RT-PCR in lymph node (LN) samplings of patients undergoing hysterectomy for endometrial carcinoma. Method. We used the RT-PCR method to determine the expression of CK-20 in the LNs of 20 patients [study group (SG)] who were being surgically staged and treated for endometrial carcinoma. The specificity of the mRNA CK-20 marker was examined in LNs obtained from five healthy patients [control group (CG)] who underwent abdominal hysterectomy and bilateral salpingo-oopherectomy for benign gynecologic conditions. The LNs obtained from the SG and CG patients were prepared together before mRNA extraction. RNA of the various cell pellets was extracted and RT-PCR was performed with CK-20 primers. RT-PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining against PCR size markers. Specificity of the RT-PCR products was examined by Southern blotting. Results. Histopathologic examinations demonstrated the presence of metastases in two (10%) SG patients. These patients were also CK-20 positive. Of the remaining 18 patients with negative histopathologic results, 6 (33%) were CK-20 positive and 12 (67%) were negative. All the CG patients were CK-20 negative (specificity, 100%). Conclusions. The results obtained in this study suggest that RT-PCR of CK-20 is more sensitive than traditional histopathologic methods in the diagnosis of MMs in LNs of patients with endometrial cancer. Thus, due to the aforementioned characteristics of CK-20, it may be considered a powerful biomarker in the detection of MMs in LNs of patients with endometrial cancer.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer</title>
<author>
<name sortKey="Fishman, A" sort="Fishman, A" uniqKey="Fishman A" first="A." last="Fishman">A. Fishman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Gynecologic Oncology Unit, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Klein, A" sort="Klein, A" uniqKey="Klein A" first="A." last="Klein">A. Klein</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Molecular Biology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zemer, R" sort="Zemer, R" uniqKey="Zemer R" first="R." last="Zemer">R. Zemer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Molecular Biology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zimlichman, S" sort="Zimlichman, S" uniqKey="Zimlichman S" first="S." last="Zimlichman">S. Zimlichman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Molecular Biology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bernheim, J" sort="Bernheim, J" uniqKey="Bernheim J" first="J." last="Bernheim">J. Bernheim</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Pathology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cohen, I" sort="Cohen, I" uniqKey="Cohen I" first="I." last="Cohen">I. Cohen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Obstetrics and Gynecology, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Altaras, M M" sort="Altaras, M M" uniqKey="Altaras M" first="M. M." last="Altaras">M. M. Altaras</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Gynecologic Oncology Unit, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">00-0311921</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0311921 INIST</idno>
<idno type="RBID">Pascal:00-0311921</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000029</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000002</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000025</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000025</idno>
<idno type="wicri:doubleKey">0090-8258:2000:Fishman A:detection:of:micrometastasis</idno>
<idno type="wicri:Area/Main/Merge">000744</idno>
<idno type="wicri:Area/Main/Curation">000736</idno>
<idno type="wicri:Area/Main/Exploration">000736</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer</title>
<author>
<name sortKey="Fishman, A" sort="Fishman, A" uniqKey="Fishman A" first="A." last="Fishman">A. Fishman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Gynecologic Oncology Unit, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Klein, A" sort="Klein, A" uniqKey="Klein A" first="A." last="Klein">A. Klein</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Molecular Biology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zemer, R" sort="Zemer, R" uniqKey="Zemer R" first="R." last="Zemer">R. Zemer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Molecular Biology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zimlichman, S" sort="Zimlichman, S" uniqKey="Zimlichman S" first="S." last="Zimlichman">S. Zimlichman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Molecular Biology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bernheim, J" sort="Bernheim, J" uniqKey="Bernheim J" first="J." last="Bernheim">J. Bernheim</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Pathology Laboratory, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cohen, I" sort="Cohen, I" uniqKey="Cohen I" first="I." last="Cohen">I. Cohen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Obstetrics and Gynecology, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Altaras, M M" sort="Altaras, M M" uniqKey="Altaras M" first="M. M." last="Altaras">M. M. Altaras</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Gynecologic Oncology Unit, Sapir Medical Center, Meir Hospital</s1>
<s2>Kfar Saba, 44281</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Kfar Saba, 44281</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Gynecologic oncology</title>
<title level="j" type="abbreviated">Gynecol. oncol.</title>
<idno type="ISSN">0090-8258</idno>
<imprint>
<date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Gynecologic oncology</title>
<title level="j" type="abbreviated">Gynecol. oncol.</title>
<idno type="ISSN">0090-8258</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cytokeratin</term>
<term>Endometrium</term>
<term>Female</term>
<term>Human</term>
<term>Immunohistochemistry</term>
<term>Lymphatic dissemination</term>
<term>Malignant lymphadenopathy</term>
<term>Malignant tumor</term>
<term>Polymerase chain reaction</term>
<term>Reverse transcription</term>
<term>Tumoral marker</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Cytokératine</term>
<term>Marqueur tumoral</term>
<term>Tumeur maligne</term>
<term>Endomètre</term>
<term>Réaction chaîne polymérase</term>
<term>Transcription inverse</term>
<term>Dissémination lymphatique</term>
<term>Adénopathie maligne</term>
<term>Immunohistochimie</term>
<term>Homme</term>
<term>Femelle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background. Cytokeratins are constituents of the intermediate filaments (IFs) of epithelial cells which are expressed in various combinations, depending on the type of epithelium and degree of differentiation. We have reported (R. Zemer, A. Fishman, J. Bernheim, S. Zimlichman, O. Markowitz, M. Altaras, and A. Klein, Gynecol Oncol 70:410-413, 1998) on the determination of cytokeratin-20 (CK-20) by reverse transcription polymerase chain reaction (RT-PCR) in the detection of endometrial cancer cells as a potential biomarker. In that study, we also found that by using immunocytochemistry, most carcinomas were found to be negative for CK-20. The sensitivity and specificity rates obtained by using the RT-PCR method were 94.4 and 91%, respectively. Objective. The aim of this study is to investigate the feasibility and potential of the specific mRNA marker, CK-20, to detect endometrial cancer cells-micrometastases (MMs)-by RT-PCR in lymph node (LN) samplings of patients undergoing hysterectomy for endometrial carcinoma. Method. We used the RT-PCR method to determine the expression of CK-20 in the LNs of 20 patients [study group (SG)] who were being surgically staged and treated for endometrial carcinoma. The specificity of the mRNA CK-20 marker was examined in LNs obtained from five healthy patients [control group (CG)] who underwent abdominal hysterectomy and bilateral salpingo-oopherectomy for benign gynecologic conditions. The LNs obtained from the SG and CG patients were prepared together before mRNA extraction. RNA of the various cell pellets was extracted and RT-PCR was performed with CK-20 primers. RT-PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining against PCR size markers. Specificity of the RT-PCR products was examined by Southern blotting. Results. Histopathologic examinations demonstrated the presence of metastases in two (10%) SG patients. These patients were also CK-20 positive. Of the remaining 18 patients with negative histopathologic results, 6 (33%) were CK-20 positive and 12 (67%) were negative. All the CG patients were CK-20 negative (specificity, 100%). Conclusions. The results obtained in this study suggest that RT-PCR of CK-20 is more sensitive than traditional histopathologic methods in the diagnosis of MMs in LNs of patients with endometrial cancer. Thus, due to the aforementioned characteristics of CK-20, it may be considered a powerful biomarker in the detection of MMs in LNs of patients with endometrial cancer.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Israël</li>
</country>
</list>
<tree>
<country name="Israël">
<noRegion>
<name sortKey="Fishman, A" sort="Fishman, A" uniqKey="Fishman A" first="A." last="Fishman">A. Fishman</name>
</noRegion>
<name sortKey="Altaras, M M" sort="Altaras, M M" uniqKey="Altaras M" first="M. M." last="Altaras">M. M. Altaras</name>
<name sortKey="Bernheim, J" sort="Bernheim, J" uniqKey="Bernheim J" first="J." last="Bernheim">J. Bernheim</name>
<name sortKey="Cohen, I" sort="Cohen, I" uniqKey="Cohen I" first="I." last="Cohen">I. Cohen</name>
<name sortKey="Klein, A" sort="Klein, A" uniqKey="Klein A" first="A." last="Klein">A. Klein</name>
<name sortKey="Zemer, R" sort="Zemer, R" uniqKey="Zemer R" first="R." last="Zemer">R. Zemer</name>
<name sortKey="Zimlichman, S" sort="Zimlichman, S" uniqKey="Zimlichman S" first="S." last="Zimlichman">S. Zimlichman</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000736 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000736 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    BernheimV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:00-0311921
   |texte=   Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Mar 5 17:33:33 2018. Site generation: Thu Apr 29 15:49:51 2021